This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02416/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB02416/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02416/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02416/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02416/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02416
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02416 n14:DB02416
dcterms:title
2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
adms:identifier
n9:DB02416 n10:RPP n11:2588959 n12:46936375 n13:46505819
n3:IUPAC-Name
n4:271B5BD2-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5BD8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5BD7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5BD4-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5BD5-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5BD6-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5BD0-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5BCE-363D-11E5-9242-09173F13E4C5 n4:271B5BD1-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5BCF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5BDE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5BDF-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5BD9-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5BDA-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5BDC-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5BDB-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5BDD-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5BE4-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5BE6-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5BE7-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5BE3-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5BE2-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5BE5-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5BD3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5BE0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5BE1-363D-11E5-9242-09173F13E4C5